Topical formulations for the symptomatic treatment of musculoskeletal disorders

摘要

Disclosed are topical compositions containing: a) capsaicin or extracts containing them; b) boswellic acids or Boswellia serrata resin extracts containing them; c) escin in free form or complexed with beta-sitosterol and/or with phospholipids or Aesculus hippocastanum seed extracts.